opc-61815
Small moleculeexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Nov 13, 2017 (NCT03254108)
Timeline
Indications
Mechanism of action
- Vasopressin V2 receptorANTAGONIST
AVPR2 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05439148 | Phase 1 | Jun 30, 2022 | Chinese Academy of Medical Sciences, Otsuka |
| NCT04182958 | Phase 1 | Dec 31, 2019 | Otsuka |
| NCT03962101 | Phase 3 | Jun 30, 2019 | Otsuka |
| NCT03772041 | Phase 3 | Jan 16, 2019 | Otsuka |
| NCT03510663 | Phase 1 | May 8, 2018 | Otsuka |
| NCT03254108 | N/A | Nov 13, 2017 | Otsuka |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Otsuka | For profit | 6 | 6 | 3 | 2017 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1